XML 16 R6.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
ATM Facility
Common Stock
Common Stock
ATM Facility
Additional Paid-in Capital
Additional Paid-in Capital
ATM Facility
Accumulated Other Comprehensive Loss Investments
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2020     140,449,647          
Beginning balance at Dec. 31, 2020 $ (9,227)   $ 140   $ 306,554     $ (315,921)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) (55,512)             (55,512)
Share-based compensation 958       958      
Exercise of stock options (in shares)     30,610          
Exercises of stock options 39       39      
Exercise of common stock warrants (in shares)     852,840          
Exercises of common stock warrants 469   $ 1   468      
Issuance of common stock and common stock warrants (in shares)       30,645,702        
Issuance of common stock and common stock warrants   $ 72,543   $ 31   $ 72,512    
Ending balance (in shares) at Mar. 31, 2021     171,978,799          
Ending balance at Mar. 31, 2021 9,270   $ 172   380,531     (371,433)
Beginning balance (in shares) at Dec. 31, 2020     140,449,647          
Beginning balance at Dec. 31, 2020 (9,227)   $ 140   306,554     (315,921)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) (9,280)              
Unrealized gain of investments 0              
Ending balance (in shares) at Sep. 30, 2021     199,463,645          
Ending balance at Sep. 30, 2021 161,008   $ 199   486,010     (325,201)
Beginning balance (in shares) at Mar. 31, 2021     171,978,799          
Beginning balance at Mar. 31, 2021 9,270   $ 172   380,531     (371,433)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) (25,442)             (25,442)
Share-based compensation 1,260       1,260      
Issuance of common stock and common stock warrants (in shares)       16,482,152        
Issuance of common stock and common stock warrants   64,261   $ 16   64,245    
Ending balance (in shares) at Jun. 30, 2021     188,460,951          
Ending balance at Jun. 30, 2021 49,349   $ 188   446,036     (396,875)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) 71,674             71,674
Share-based compensation 1,168       1,168      
Exercise of stock options (in shares)     3,000          
Exercises of stock options 3       3      
Exercise of common stock warrants (in shares)     1,195,219          
Exercises of common stock warrants 657   $ 1   656      
Issuance of common stock and common stock warrants (in shares)       9,804,475        
Issuance of common stock and common stock warrants   $ 38,157   $ 10   $ 38,147    
Unrealized gain of investments 0              
Ending balance (in shares) at Sep. 30, 2021     199,463,645          
Ending balance at Sep. 30, 2021 161,008   $ 199   486,010     (325,201)
Beginning balance (in shares) at Dec. 31, 2021     199,463,645          
Beginning balance at Dec. 31, 2021 171,710   $ 199   487,768   $ 0 (316,257)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) (807)             (807)
Share-based compensation 1,894       1,894      
Ending balance (in shares) at Mar. 31, 2022     199,463,645          
Ending balance at Mar. 31, 2022 172,797   $ 199   489,662   0 (317,064)
Beginning balance (in shares) at Dec. 31, 2021     199,463,645          
Beginning balance at Dec. 31, 2021 171,710   $ 199   487,768   0 (316,257)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) $ (12,310)              
Exercise of stock options (in shares) 0              
Exercise of common stock warrants (in shares) 0              
Unrealized gain of investments $ (235)              
Ending balance (in shares) at Sep. 30, 2022     202,757,012          
Ending balance at Sep. 30, 2022 165,029   $ 202   493,629   (235) (328,567)
Beginning balance (in shares) at Mar. 31, 2022     199,463,645          
Beginning balance at Mar. 31, 2022 172,797   $ 199   489,662   0 (317,064)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) (31,960)             (31,960)
Share-based compensation 1,802       1,802      
Unrealized gain of investments (281)           (281)  
Ending balance (in shares) at Jun. 30, 2022     199,463,645          
Ending balance at Jun. 30, 2022 142,358   $ 199   491,464   (281) (349,024)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) 20,457             20,457
Share-based compensation (in shares)     3,293,367          
Share-based compensation 2,168   $ 3   2,165      
Unrealized gain of investments 46           46  
Ending balance (in shares) at Sep. 30, 2022     202,757,012          
Ending balance at Sep. 30, 2022 $ 165,029   $ 202   $ 493,629   $ (235) $ (328,567)